Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Published on by Cell Biologist

Ms. Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Department of Stomatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R | China

Professor Wu Lin is a leading scholar in oral rehabilitation and biomaterials research, recognized for her extensive contributions to bone implant materials and advanced technologies for dental restoration. Her work spans more than 90 peer-reviewed publications across high-impact national and international journals, reflecting sustained productivity and influence in stomatology research. She has led major scientific initiatives, including national natural science projects, a “14th Five-Year Plan” National Key R&D project, national disaster-related research, multiple sub-projects under the national “863” Plan, and several provincial-level grants. As the first inventor, she holds two authorized invention patents that advance the design and performance of oral implant systems. Her editorial roles in multiple scientific journals and participation in specialized professional committees further demonstrate her leadership in shaping research directions in oral medicine, prosthodontics, and biomaterials science. Through her innovations, Professor Wu has significantly advanced clinical applications and material technologies in modern stomatology.

Citation Metrics (Scopus)
800

600

400

200

0

Citations
719

Documents
50

h-index
15

Citations
Documents
h-index



View Scopus Profile


Featured Publications

Junning Ma | Cell Surface Receptors | Best Research Article Award

Published on by Cell Biologist

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironment–responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the blood–brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications: 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membrane–coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Arzu Yay | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Arzu Yay | Stem Cell Research | Best Researcher Award

Erciyes University | Turkey

Prof. Arzu Yay is a distinguished researcher in the Department of Histology and Embryology at Erciyes University, Turkey. Her work focuses on cellular and molecular mechanisms underlying tissue development, injury, and repair, with emphasis on immunohistochemical and ultrastructural analyses. Her M.Sc. research examined E-cadherin expression during renal development in the prenatal period, contributing to the understanding of epithelial differentiation in organogenesis. Her Ph.D. focused on nestin expression across different grades of meningiomas and glioblastomas, highlighting neural stem cell marker dynamics in tumor progression. She has conducted significant studies on oxidative stress, neurobiology, and tissue damage, including investigations into the effects of melatonin and vitamin C on alcohol-induced lung injury and nitric oxide synthase immunoreactivity. Her research has also explored tissue-level alterations in diabetes and the histological impacts of hormonal and anesthetic agents. Prof. Yay’s postdoctoral work at the University of Lübeck, Germany, further advanced her expertise in dermatological histopathology. Her contributions have been recognized through multiple national and international awards for excellence in experimental and translational research, particularly in antioxidant mechanisms and radioprotection. Her body of work reflects a strong integration of histological, molecular, and ultrastructural approaches in biomedical sciences.

Profiles: Google Scholar | Scopus

Featured Publications:

Yıldız, K., Efesoy, S. N., Ozdamar, S., Yay, A., Bicer, C., Aksu, R., & Kılıc, E. (2011). Myotoxic effects of levobupivacaine, bupivacaine and ropivacaine in a rat model. Clinical Investigation in Medicine, 34(5), 273–280.

Sarıozkan, S., Bucak, M. N., Canturk, F., Ozdamar, S., Yay, A., Tuncer, P. B., Ozcan, S., Sorgucu, N., & Caner, Y. (2012). The effects of different sugars on motility, morphology and DNA damage during the liquid storage of rat epididymal sperm at 4°C. Cryobiology, 65(2), 93–97.

Sarıozkan, S., Canturk, F., Yay, A., & Akçay, A. (2012). The effect of different storage temperature on sperm parameters and DNA damage in liquid stored New Zealand rabbit spermatozoa. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 18(3), 475–480.*

Yay, A., Ozdamar, S., Canoz, O., Tucer, B., & Baran, M. (2013). Nestin expression in meningiomas of different grades. Journal of Neurological Sciences (Turkish), 30, 532–540.

Sarıozkan, S., Türk, G., Canturk, F., Yay, A., Eken, A., & Akçay, A. (2013). The effect of bovine serum albumin and fetal calf serum on sperm quality, DNA fragmentation and lipid peroxidation of liquid stored rabbit semen. Cryobiology, 67(1), 1–6.*

Ernst, N., Yay, A., Bíró, T., Tiede, S., Humphries, M., Paus, R., & Kloepper, J. E. (2013). β1 integrin signaling maintains human epithelial progenitor cell survival in situ and controls proliferation, apoptosis and migration of their progeny. PLoS ONE, 8(12), e84356.*

Yay, A., Ozdamar, S., Canoz, O., Baran, M., Tucer, B., & Sonmez, M. F. (2014). Intermediate filament protein nestin is expressed in developing meninges. Bratislava Medical Journal, 115(11), 718–722.*

Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Published on by Cell Biologist

Dr. Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo, ASP CALTANISSETTA, Italy

Maria Andriolo is a dedicated biomedical researcher and clinical biologist with extensive experience in neuroscience, immunology, and post-traumatic disorders. Her multidisciplinary approach has led to impactful contributions in clinical diagnostics, neurorehabilitation, and infectious disease studies. With decades of experience across leading Italian institutions, she combines clinical insight with scientific rigor. She has served in prestigious roles such as a Member of the State Examination Commission and President of Public Selection Committees. Dr. Andriolo is widely published, collaborating on pioneering studies in fields including brain trauma, sepsis diagnostics, and vaccine immunoresponse. Known for her collaborative spirit and leadership, she also contributes as a conference moderator and educator. Her body of work reflects a deep commitment to translational science that benefits patient care and public health.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Multidisciplinary Research Impact
    Dr. Andriolo’s work spans key medical research areas including:

    • Neurology (e.g., traumatic brain injury, disorders of consciousness)

    • Clinical Biochemistry (e.g., neuron-specific enolase, BDNF, CSF biomarkers)

    • Microbiology & Infectious Diseases (e.g., antimicrobial resistance, sepsis diagnostics)

    • Immunology & Vaccine Response (e.g., post-COVID vaccine serology in healthcare workers)

  2. Innovation with Real-World Impact
    Her studies focus on biomarkers for rapid diagnosis, rehabilitation outcomes, and immune responses, directly translating into improved patient care, particularly in:

    • Post-traumatic brain disorders

    • Early detection of sepsis

    • Infection control strategies

  3. Collaborative and High-Impact Publications

    • Extensive peer-reviewed articles in PubMed-indexed journals like Journal of Neurotrauma, Brain Sciences, Vaccines, and Science Reports.

    • Publications show collaborations with leading national research teams and hospitals.

  4. Scientific Leadership & Recognition

    • Appointed as President of National Selection Committees and State Examiner for Biologist Certification.

    • Served as Moderator at ECM Conferences, further demonstrating peer trust and scientific communication skills.

⚠️ Areas for Improvement:

  1. Lead Authorship and Project Ownership

    • While her publication record is strong, she is mostly listed as co-author. Clear documentation of principal investigator roles, research grants led, or independent innovation patents would further bolster her candidacy.

  2. International Presence

    • A broader international profile (e.g., global conferences, cross-border collaborative studies, citations from non-EU entities) could elevate her global impact.

  3. Recent Innovation Highlights

    • A focused submission highlighting a single groundbreaking innovation (e.g., biomarker panel for TBI prognosis or rapid sepsis tool) would align more clearly with “Best Innovation” award criteria.

🎓 Education:

While the detailed educational background isn’t listed, Maria Andriolo’s professional and scientific achievements imply a robust academic foundation in Biology, Neuroscience, and Clinical Diagnostics, likely culminating in at least a Master’s or Doctorate-level education in Biomedical Sciences. Her involvement as a State Examiner for Biologist Qualification and leader of academic committees suggests a longstanding connection with university-level institutions, particularly the University of Messina. Given her expertise and publication record, it is evident she has received specialized training in neurobiology, molecular genetics, clinical chemistry, and medical microbiology. She has actively participated in ECM-accredited medical conferences, indicating a commitment to continuing professional development. This mix of structured education and applied training positions her as a highly qualified scientific professional.

💼 Professional Experience:

Maria Andriolo holds significant academic and clinical leadership roles. She was appointed in July 2024 as a Member of the State Examination Commission for Biologists at the University of Messina, overseeing professional certifications. In June 2023, she served as President of the Examination Committee for a public selection competition for C1 research staff. She is frequently invited to act as a moderator at ECM-accredited conferences, underscoring her peer recognition in the field. Her expertise spans biomedical research, academic evaluation, and public health diagnostics. Maria’s ability to combine scientific knowledge with regulatory oversight and teaching makes her a valuable contributor to academia and public institutions. Her leadership and participation in national scientific initiatives demonstrate her commitment to innovation, clinical application, and academic excellence.

🔬 Research Focus:

Maria Andriolo’s research is anchored in neuroscience, post-traumatic disorders, biomarkers, and infectious diseases. Her work often centers on patients with disorders of consciousness following trauma, analyzing biomarkers like BDNF, neurofilaments, and amyloid-beta proteins. She is a leading contributor in understanding the neurochemical pathways associated with brain injury and rehabilitation. Maria has also co-authored influential studies on sepsis diagnostics, immune response to COVID-19 vaccines, and antimicrobial resistance. Her research combines laboratory diagnostics with clinical applications, enabling faster diagnoses and more effective treatment strategies. She is known for utilizing multidisciplinary frameworks, involving neurologists, microbiologists, and clinicians to translate science into solutions. This strong translational impact underscores her candidacy for the Best Innovation Award, as she bridges the gap between research and patient-centered innovation.

📚 Publications Top Notes:

  1. 🧠 Reduced neuron-specific enolase levels in chronic severe traumatic brain injury

  2. 🧬 Multidisciplinary approach for the rapid diagnosis of sepsis

  3. 💉 Serological analysis of humoral immune response in Sicilian HCWs post-COVID vaccination

  4. 🧠 Dissociation of CSF amyloid-beta and tau in post-traumatic consciousness disorders

  5. 💉 Staphylococcus aureus in bloodstream infections: frequency & antimicrobial resistance

  6. 🧠 Serum BDNF levels are reduced in disorders of consciousness

  7. 🧠 Six-month outcomes in traumatic consciousness disorders (hemorrhagic/non-hemorrhagic)

  8. 🧠 BDNF Val66Met polymorphism and post-traumatic vegetative state recovery

  9. 💉 Anaphylaxis to streptomycin

  10. 🧠 Prolonged CSF neurofilament light chain increase in traumatic brain patients

🏁 Conclusion:

Maria Andriolo is a highly suitable and deserving candidate for the Research for Best Innovation Award. Her research demonstrates:

  • Exceptional depth in translational neuroscience and diagnostics

  • A strong commitment to multidisciplinary collaboration

  • A clear track record of innovation that impacts both patient outcomes and healthcare protocols